- Investing.com
Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids’ wellness, digestives, women’s health, and hygiene and protection. The company was incorporated in 2020 and is based in Mumbai, India.
Metrics to compare | PIRM | Peers Peers - average of corresponding metrics from companies closely matching PIRM: MANKIND, GLENMARK, PFIZER, ABBOTINDIA, CIPLA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPIRMPeersSector |
---|---|---|---|---|
P/E Ratio | 1,056.9x | 42.0x | −0.6x | |
PEG Ratio | 9.24 | 0.17 | 0.00 | |
Price/Book | 3.7x | 5.9x | 2.6x | |
Price / LTM Sales | 3.5x | 5.0x | 3.2x | |
Upside (Analyst Target) | 14.1% | −6.6% | 46.9% | |
Fair Value Upside | Unlock | −14.5% | 7.9% | Unlock |